Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 4862 of 5804
-
Could a tiny aspirin dose plus a blood thinner be safer for heart patients?
Knowledge-focused CompletedThe trial is a pharmacodynamic study to determine the effect of a novel regimen of aspirin 20 mg BD plus rivaroxaban 2.5 mg BD on haemostasis, fibrin clot dynamics, inflammatory markers, platelet function and arachidonic acid metabolites when compared to standard regimens of aspi…
Phase: PHASE4 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Diabetes and aspirin: new study checks if the standard dose is enough
Knowledge-focused OngoingThis phase 1 study will include patients suffering from type 2 diabetes mellitus and will study their response to enteric coated aspirin at a dose of 80 mg per day for a 7-day period. The aims are to determine the feasibility of a phase 2 larger scale trial, and to characterize t…
Phase: EARLY_PHASE1 • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Step counts may predict trouble during lung cancer therapy
Symptom relief TerminatedThis trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of rad…
Phase: NA • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New drug shows promise in early trial for advanced cancers
Disease control CompletedThis is a Phase 1 study to assess the safety and clinical activity of RO7623066 alone and in combination in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Psoriatic arthritis drug showdown: which treatment do patients stick with?
Knowledge-focused OngoingThe purpose of this study is to evaluate treatment persistence with guselkumab and interleukin-17 inhibitor (IL-17i) initiated at enrollment into this study (PsABIOnd).
Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Can a simple arm band ease tennis elbow pain?
Symptom relief Recruiting nowThe study aims to evaluate the effectiveness of Blood Flow Restriction Training for the treatment of lateral elbow epicondylopathy.
Phase: NA • Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Jun 26, 2026 17:26 UTC
-
Stomach cancer surgery combo trial fizzles: only 6 patients enrolled
Disease control TerminatedSurgical resection of the primary tumour and treatment of the metastatic site in oligometastatic stage IV metastatic gastric adenocarcinoma enhances survival and improves quality of life with acceptable postoperative morbidity and mortality in a selected group of operable patient…
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New sepsis guidelines for pregnant women put to the test
Knowledge-focused CompletedDespite advances in the diagnosis and treatment of sepsis, the studies available in the literature report very high maternal and fetal/neonatal mortality and morbidity in cases of sepsis occurring during pregnancy or the puerperium. It is the third leading cause of maternal death…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Genetic deep dive uncovers hidden clues in rare bone disease
Knowledge-focused CompletedThis study is being done to determine if cryptic alterations exist within or near to the ALPL gene in patients with a clinical diagnosis of hypophosphatasia, but without identifiable alteration on commercial testing. Additionally, the study aims to characterize functional effects…
Sponsor: Children's Mercy Hospital Kansas City • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Food delivery plus education shows promise for diabetes in Food-Insecure adults
Disease control CompletedThe goal of this study was to develop, implement, and evaluate the effectiveness of an intervention to use home-delivery of Type 2 diabetes (T2D)-appropriate food boxes with plain language adapted education materials to improve the nutritional health, physical activity, and healt…
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Experimental combo for bile duct cancer shows promise in tiny trial
Disease control CompletedThe purposed of this research is to study the safety and clinical activity of the combination of durvalumab and a CSF-1R inhibitor (SNDX-6352) in people with Intrahepatic Cholangiocarcinoma.
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Zapping nerves with ultrasound: a new hope for heart failure?
Disease control CompletedThe purpose is to evaluate the renal denervation system (PRDS-001) for controlling sympathetic nerve over-activation in patients with heart failure, and for its safety in such patients.
Phase: NA • Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Scientists pinpoint ideal painkiller dose for diabetic foot operations
Symptom relief OngoingThe purpose of this study was to determine the minimum effective dose of a local anesthetic for proper anesthesia for popliteal sciatic nerve block under ultrasound guidance in patients undergoing surgery for diabetic foot disease.
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Proton beam therapy tested for liver cancer – early results show promise and risks
Disease control TerminatedThis phase II trial studies the effect of stereotactic body proton radiotherapy in treating patients with liver cancer. Proton radiotherapy is a type of treatment that uses high-energy beams to treat tumors.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New risk tool aims to take the guesswork out of sarcoma treatment choices
Knowledge-focused OngoingThe goal of this clinical trial is to assess the (cost-)effectiveness of a personalised risk assessment tool (PERSARC) to increase patients' knowledge about risks and benefits of treatment options and to reduce decisional conflict in comparison with usual care in high-grade extre…
Phase: NA • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:17 UTC
-
Gut bugs may boost flu vaccine power
Knowledge-focused OngoingThis study evaluates the association between gut microbiome and dietary determinants and vaccine response. This study aims to learn if diet and the microbes (such as bacteria and viruses) found in your gut affect the body's immune response to the influenza vaccine.
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Rare disease detection: new study measures porphyria prevalence in symptomatic patients
Knowledge-focused CompletedTo determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent for a suggestive clinical picture with a first negative etiological assessment.
Sponsor: Association pour la Recherche en Medecine Interne • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
3D tool may boost satisfaction in breast reconstruction decisions
Symptom relief OngoingThe purpose of this study is to find out whether using an interactive 3D tool during a standard surgical consultation can lead to greater patient satisfaction with the information provided about breast reconstruction options than the standard consultation alone. The study researc…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 26, 2026 15:34 UTC
-
New cholesterol drug shows promise for seniors in 6-Month study
Disease control CompletedA prospective, open, observational study to confirm the lipid-lowering effect, changes in glucose metabolism, and safety after 6 months of administration of atostazet to hypercholesterolemic patients 65 years of age or older
Sponsor: Dong Wha Pharmaceutical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New implant aims to silence severe ringing in the ears
Symptom relief CompletedResearchers are gathering information on the safety and effectiveness of a novel device called the Tinnitus Implant System for the treatment of tinnitus.
Phase: NA • Sponsor: Matthew L. Carlson, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC